Page last updated: 2024-08-16

ribavirin and Colitis-Associated Cancer

ribavirin has been researched along with Colitis-Associated Cancer in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Chen, X; Chen, Y; Ge, S; Li, F; Tian, Y; Yang, R; Zhang, B; Zhang, Q	1

Other Studies

1 other study(ies) available for ribavirin and Colitis-Associated Cancer

Article	Year
Ribavirin inhibits colorectal cancer growth by downregulating PRMT5 expression and H3R8me2s and H4R3me2s accumulation. Toxicology and applied pharmacology, 2021, 03-15, Volume: 415 Topics: Animals; Antineoplastic Agents; Cell Proliferation; Colitis-Associated Neoplasms; Colorectal Neoplasms; DNA Methylation; Down-Regulation; Eukaryotic Initiation Factor-4E; Female; Gene Expression Regulation, Neoplastic; HCT116 Cells; Histones; Humans; Mice, Inbred ICR; Promoter Regions, Genetic; Protein-Arginine N-Methyltransferases; Ribavirin; S Phase Cell Cycle Checkpoints; Signal Transduction; Tumor Burden	2021

Article

Year

Ribavirin inhibits colorectal cancer growth by downregulating PRMT5 expression and H3R8me2s and H4R3me2s accumulation.

Toxicology and applied pharmacology, 2021, 03-15, Volume: 415

Topics: Animals; Antineoplastic Agents; Cell Proliferation; Colitis-Associated Neoplasms; Colorectal Neoplasms; DNA Methylation; Down-Regulation; Eukaryotic Initiation Factor-4E; Female; Gene Expression Regulation, Neoplastic; HCT116 Cells; Histones; Humans; Mice, Inbred ICR; Promoter Regions, Genetic; Protein-Arginine N-Methyltransferases; Ribavirin; S Phase Cell Cycle Checkpoints; Signal Transduction; Tumor Burden

2021